Travoprost

A prostaglandin analogue, it is used to reduce intra-ocular pressure in ocular hypertension or in open-angle glaucoma. Patients receiving prostaglandins should be monitored for any changes to eye coloration since an insrease in the brown pigment in the iris may occur.

Brands
TRAVATAN RAVAT
Adult Dose
Dose: 4 to 8 mcg
Single Dose: 6 (6)
Frequency: As recommended.
Route: Topical (Ophthalmic)
Instructions: Apply once daily.
Neonatal
Paedriatic
Characteristics
. It is of Synthetic origin. .
Contraindications
Travoprost
Effects
The symptomatic adverse reactions produced by Travoprost are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dyspnea, Blepharitis, Brown pigmentation particularly in those with mixed-color irides, Ocular irritation and pain, Darkening, thickening, and lenghtening of eye lashes, Periorbital and lid edema, Transient punctate epithelial erosions, Exacerbation of asthma, Local skin reaction, Macular edema, Irritis and uveitis, Darkening of palpebral skin.
Indications
Travoprost is primarily indicated in conditions like Ocular hypertension, and can also be given in adjunctive therapy as an alternative drug of choice in Sedative in combined anaesthesia.
Interactions
No data regarding the interactions of Travoprost was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Before initiating treatment, advise patients of possible change in eye colour; monitor for eye colour change; aphakia, or pseudophakia with torn posterior lens capsule or anterior chamber lenses; risk factors for cystoid macular oedema; brittle or severe asthma; not to be used within 5 minutes of use of thiomersal-containing preparations; avoid in pregnancy and breast-feeding.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.